- In April 2023, CooperSurgical, Inc. announced the expansion of its manufacturing facility in Denmark to scale up production of advanced surgical instruments for gynecologic and uro-gynecologic procedures. The expansion aims to meet rising global demand for minimally invasive solutions and reflects CooperSurgical’s strategic focus on innovation in women's health. This move strengthens the company’s global supply chain and enhances its ability to deliver high-quality surgical products for pelvic health treatments
- In March 2023, Intuitive Surgical, Inc. launched its next-generation robotic-assisted surgical platform for gynecologic applications, featuring enhanced visualization, smaller instrumentation, and improved ergonomic design for surgeons. This system supports complex uro-gynecologic procedures such as pelvic organ prolapse repair and hysterectomy, showcasing Intuitive’s commitment to advancing precision surgery and improving patient outcomes through cutting-edge technology
- In March 2023, Olympus Corporation introduced an updated range of hysteroscopes and operative instruments aimed at expanding its minimally invasive gynecology portfolio. These devices offer improved optics and reduced invasiveness, enabling more effective treatment of uterine conditions. The launch reinforces Olympus’s role in driving endoscopic innovation and aligns with the broader market trend towards less invasive, high-precision uro-gynecologic interventions
- In February 2023, Boston Scientific Corporation partnered with leading healthcare institutions in Europe to conduct clinical trials evaluating the long-term safety and efficacy of new implantable devices for stress urinary incontinence. This initiative reflects Boston Scientific’s continued focus on evidence-based innovation and regulatory compliance, supporting global trust in advanced uro-gynecologic devices
- In January 2023, Medtronic plc unveiled its expanded suite of energy-based surgical devices designed for precision cutting and coagulation during pelvic surgeries. Showcased at the Global Congress on Minimally Invasive Gynecology, these tools cater to procedures such as myomectomy and endometrial ablation. The launch demonstrates Medtronic’s investment in comprehensive, technology-driven surgical platforms that address the evolving needs of uro-gynecologic care providers
